Impact of ocular surface symptoms on quality of life in a United States Veterans Affairs population
Peer Reviewed
-
2012/06/01
Details
-
Personal Author:
-
Description:PURPOSE: To evaluate the impact of ocular surface symptoms on quality of life in a veteran population receiving eye care services. DESIGN: Cross-sectional survey study. METHODS: Setting: Miami Veterans Affairs Medical Center (VAMC). Patient Population: Patients seen at the eye clinic between June and August 2010 were asked to fill out the Dry Eye Questionnaire 5 (DEQ5) and the Impact of Dry Eye on Everyday Life (IDEEL) questionnaire. Main Outcome Measures: Correlation between ocular surface symptoms and functionality. RESULTS: Four hundred eighty-nine patients elected to fill out the DEQ5 questionnaire (36% response rate). The mean age of respondents was 66 years (standard deviation 12). Ninety-four percent were male; 62% were white and 37% were black. Using the DEQ5 as a surrogate measure of ocular surface symptoms, 65% of respondents reported at least mild ocular surface symptoms (DEQ5 =6) and 27% of them reported severe symptoms (DEQ5 =12). Black subjects had a 2-fold increased risk of severe symptoms compared to white subjects (odds ratio 2.06, 95% confidence interval 1.33-3.19). Several medications were associated with a significantly increased risk of severe symptoms, including glaucoma medications (1.7-fold increase), antidepressants (2.3-fold increase), and antihistamines (2.1-fold increase). There was an inverse correlation between DEQ5 and IDEEL scores with regard to ability to perform activities of daily living (n = 391, r = -0.54, P < .001), emotional well-being (n = 386, r = -0.63, P < .001), and the ability to work (n = 205, r = -0.57, P < .001). Fifty percent of patients with severe symptoms had documentation that their symptoms were addressed during the visit. CONCLUSION: Severe ocular surface symptoms reduce the quality of life of Miami VAMC veterans. Eye care professionals should be vigilant in eliciting ocular surface complaints from their patients. Description provided by NIOSH
-
Subjects:
-
Keywords:
-
ISSN:0002-9394
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:153
-
Issue:6
-
NIOSHTIC Number:nn:20041305
-
Citation:Am J Ophthalmol Jun; 153(6):1061-1066.e3
-
Contact Point Address:Anat Galor, 900 NW 17th St, Miami, FL 33136
-
Email:agalor@med.miami.edu
-
Federal Fiscal Year:2012
-
Performing Organization:University of Miami School of Medicine
-
Peer Reviewed:True
-
Start Date:20020901
-
Source Full Name:American Journal of Ophthalmology
-
End Date:20130831
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b67940e2e5fe3d2def321c2725c0336814e998f30b20d4d445cd2578e649ad4cda53084f19e009ae4316d8b13569ed46046adb92de8224b4ebdcf3e27f938ff7
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like